Stockreport

BRIEF-Roche Holding Says EMA Grants Prime Designation For Risdiplam For Treatment Of SMA [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF BRIEF-Roche Holding Says EMA Grants Prime Designation For Risdiplam For Treatment Of SMA | Reuters 1 Min Read Dec 17 (Reuters) - Roche Holding AG: * SAYS PRIME DESIGNATI [Read more]